Salarius Pharmaceuticals
-$0.0222 (-4.70%) As of 8:12 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLRX and other ETFs, options, and stocks.
About SLRX
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company. The firm focuses on the development of Salarius’ clinical pipeline, which targets rare, orphan cancers and cancers with a high unmet need.
CEO
David J. Arthur
Employees
9
Headquarters
Houston, Texas
Founded
2014
SLRX Key Statistics
Market cap
20.45M
Price-Earnings ratio
—
Dividend yield
—
Average volume
390.13K
High today
$0.4801
Low today
$0.45
Open price
$0.479
Volume
211.49K
52 Week high
$3.50
52 Week low
$0.45
SLRX Earnings
-$0.13
-$0.09
-$0.04
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 17, After Hours